Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1
Bridget S. Gosis(Cardiovascular Institute of the South), Zoltàn Arany(University of Pennsylvania), Cholsoon Jang(University of California, Irvine), Kristina Li(Cardiovascular Institute of the South), Marc R. Bornstein(University of Pennsylvania), Li Li(University of Pennsylvania), Yifan Yang(Cardiovascular Institute of the South), Sudha B. Biddinger(Boston Children's Hospital), Nathan B. Sanford(Cardiovascular Institute of the South), Chelsea Thorsheim(Cardiovascular Institute of the South), Paul M. Titchenell(University of Pennsylvania), Kahealani Uehara(University of Pennsylvania), Joshua H. Rhoades(Cardiovascular Institute of the South), Sunhye Jeong(Korea Advanced Institute of Science and Technology), Matthew Lanza(University of Pennsylvania), Jeffrey Brandimarto(University of Pennsylvania), Shogo Wada(University of Pennsylvania), Sunhee Jung(University of California, Irvine)
Cited by 156
Related Papers
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure
|Nature Communications|2020|924
Branched Chain Amino Acids
|Annual Review of Physiology|2018|686
Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy
|Circulation|2019|344
SLC25A51 is a mammalian mitochondrial NAD+ transporter
|Nature|2020|301